webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Mal-PEG3-NHS ester

  CAS No.: 1537892-36-6   Cat No.: BADC-00603   Purity: ≥95% 4.5  

Mal-PEG3-NHS ester is a non-cleavable ADC linker containing the Maleimide group. It can be used to prepare antibody conjugated drugs (ADCs).

Mal-PEG3-NHS ester

Structure of 1537892-36-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C17H22N2O9
Molecular Weight
398.37
Shipping
Room temperature, or blue ice upon request.
Shipping
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Mal-PEG3-NHS; 2,5-Dioxo-1-pyrrolidinyl 3-[2-[2-[2-(2,5-dioxo-2,5-dihydro-1-pyrrolyl)ethoxy]ethoxy]ethoxy]propanoate; Propanoic acid, 3-[2-[2-[2-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)ethoxy]ethoxy]ethoxy]-, 2,5-dioxo-1-pyrrolidinyl ester; 2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethoxy)ethoxy)ethoxy)propanoate; 1-{2-[2-(2-{3-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-3-oxopropoxy}ethoxy)ethoxy]ethyl}-1H-pyrrole-2,5-dione; 1H-Pyrrole-2,5-dione, 1-[2-[2-[2-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropoxy]ethoxy]ethoxy]ethyl]-
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]ethoxy]propanoate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCN2C(=O)C=CC2=O
InChI
InChI=1S/C17H22N2O9/c20-13-1-2-14(21)18(13)6-8-26-10-12-27-11-9-25-7-5-17(24)28-19-15(22)3-4-16(19)23/h1-2H,3-12H2
InChIKey
IIXXEVQHRSMNOB-UHFFFAOYSA-N
Density
1.39±0.1 g/cm3 (Predicted)
Solubility
Soluble in DCM, DMSO
Appearance
Pale Yellow Oily Matter
Shipping
Room temperature, or blue ice upon request.
Storage
Store at 2-8°C
Boiling Point
552.4±60.0°C (Predicted)

Mal-PEG3-NHS ester, a versatile chemical reagent in bioconjugation with diverse applications in bioscience and biotechnology, is a key player in various domains.

Protein Modification: Through the intricate process of PEGylation, Mal-PEG3-NHS ester assumes a crucial role in the modification of proteins by the addition of polyethylene glycol (PEG) chains to their surfaces. This modification significantly boosts protein stability, solubility, and in vivo half-life, establishing itself as a cornerstone in therapeutic protein development. The selective conjugation of PEG to lysine residues on proteins via the NHS ester group allows for targeted enhancements of their properties.

Antibody Conjugation: In addition to its role in protein modification, Mal-PEG3-NHS ester facilitates the conjugation of antibodies with diverse molecules like fluorescent dyes or drug compounds, paving the way for groundbreaking diagnostic applications and precise targeted therapy. The maleimide group within this compound exhibits specificity in reacting with thiol groups, enabling site-specific labeling of antibody fragments. This tailored conjugation strategy plays a pivotal role in the evolution of antibody-drug conjugates (ADCs) and the refinement of diagnostic assays with unparalleled accuracy.

Surface Coating: Leveraging its unique properties, Mal-PEG3-NHS ester emerges as an indispensable tool for surface coating applications aimed at reducing non-specific binding and enhancing biocompatibility across a spectrum of biomedical devices. By establishing PEGylated layers on surfaces, researchers create barriers to protein adsorption and cell adhesion, a strategic approach widely embraced in the design of biosensors, microarrays, and implantable devices to optimize performance and safety through tailored modifications.

Cellular Imaging: In the domain of cellular imaging, the versatility of Mal-PEG3-NHS ester shines brightly, facilitating the conjugation of imaging probes to biomolecules for unrivaled visualization of specific proteins and cellular components. This precise labeling assists researchers in delving into dynamic cellular processes and intricate protein interactions using cutting-edge imaging modalities like fluorescence microscopy.

1.Immobilization of hydrophobic peptidic ligands to hydrophilic chromatographic matrix: a preconcentration approach
Gautam S, Loh KC.
This study presents a methodology for covalent attachment of hydrophobic peptidic ligands to hydrophilic chromatographic matrices with improved coupling efficiency. Preconcentration was introduced through the use of polyethylene glycol (PEG)-based crosslinkers. Immobilization of model hydrophobic peptide pep12 (ITLISSEGYVSS) to hydrophilic silica-amine matrix was investigated in the absence/presence of PEG-based linker. The effect of linker densities 14.2, 27.6, and 56.4 μmol/g beads on coupling efficiency was investigated. Whereas a ligand coupling efficiency of 67% was obtained in the absence of the linker, incorporating PEG-based linker at low densities allowed a 30% increase in the coupling efficiency. Although the heterobifunctional crosslinker, maleimide-PEG-NHS (N-hydroxysuccinimide) ester, can be used to couple thiol-bearing ligands to amine-functionalized matrices, no method is available for quenching free amine moieties on the matrix after ligand immobilization. The efficacy of acylating agents, acetyl chloride and oxalyl chloride, in blocking free amine groups when immobilizing the model peptide pep14 (CITLISSEGYVSSK) to silica-amine matrix using maleimide-PEG-NHS ester crosslinker was investigated. Because oxalyl chloride was nonreactive to maleimides, it allowed successful coupling of pep14 to the maleimide termini of the linkers. Adsorption studies between pep14-immobilized microspheres and human immunoglobulin M (hIgM) suggested retention of ligand activity and a 95% decrease in nonspecific binding of proteins to the matrix.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Mal-PEG4-VC-PAB-DMEA | perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate | perfluorophenyl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate | perfluorophenyl 3-(2-(4-formylbenzamido)ethoxy)propanoate | Ald-Ph-amido-PEG2-C2-Pfp ester | Mal-amido-PEG2-Val-Cit-PAB-OH | Mal-amido-(CH2COOH)2 | Fmoc-Phe-Lys(Boc)-PAB-PNP | Mal-amido-PEG8-val-gly-PAB-OH | Mal-amido-PEG2-NHS | Mal-PEG3-NHS ester
Send Inquiry
Verification code
Inquiry Basket